Sandy Eldridge

Frederick National Laboratory for Cancer Research

Also affiliated with National Cancer Institute

Biochemistry, Genetics and Molecular BiologyEngineeringMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Considerations for a Reliable In Vitro Model of Chemotherapy-Induced Peripheral Neuropathy”.

Considerations for a Reliable In Vitro Model of Chemotherapy-Induced Peripheral Neuropathy

Toxics(2021)10.3390/toxics9110300

N/A

0DataRank · unranked

6 citations

Arianna Scuteri, Eugenia Jones, Guido Cavaletti, Liang Guo, Elizabeth R. Glaze +1 more

Supplemental Methods from Targeting Glycolysis through Inhibition of Lactate Dehydrogenase Impairs Tumor Growth in Preclinical Models of Ewing Sarcoma

(2023)10.1158/0008-5472.22422704

N/A

0DataRank · unranked

0 citations

Anna E. Gibson, Sameer H. Issaq, Nobu Oshima, Joshua T. Baumgart, Leah D. Edessa +23 more

Supplemental Methods from Targeting Glycolysis through Inhibition of Lactate Dehydrogenase Impairs Tumor Growth in Preclinical Models of Ewing Sarcoma

Figshare(2023)10.1158/0008-5472.22422704.v1

N/A

0DataRank · unranked

0 citations

Anna E. Gibson, Sameer H. Issaq, Nobu Oshima, Joshua T. Baumgart, Leah D. Edessa +23 more

Collaborative science in action: A 20 year perspective from the Health and Environmental Sciences Institute (HESI) Cardiac Safety Committee

Journal of Pharmacological and Toxicological Methods(2024)10.1016/j.vascn.2024.107511

N/A

0DataRank · unranked

2 citations

Brian R. Berridge, Ksenia Blinova, Marjory B. Brooks, Sandy Eldridge, Claire E. O’Brien +7 more

Development of a workflow for in vitro on– and off-target cytotoxicity assessment of CAR T cell therapies to support first-in-human clinical trials: An orthogonal approach using human induced pluripotent stem cell-derived cells as a surrogate for normal vital organ systems

Current Research in Toxicology(2025)10.1016/j.crtox.2025.100243

N/A

0DataRank · unranked

1 citations

Krista G Zindel, Joshua K. Overcash, Elizabeth R. Glaze, Sandy Eldridge, Shari A. Price